Correlation Between Structure Therapeutics and Nuvectis Pharma
Can any of the company-specific risk be diversified away by investing in both Structure Therapeutics and Nuvectis Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Structure Therapeutics and Nuvectis Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Structure Therapeutics American and Nuvectis Pharma, you can compare the effects of market volatilities on Structure Therapeutics and Nuvectis Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Structure Therapeutics with a short position of Nuvectis Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Structure Therapeutics and Nuvectis Pharma.
Diversification Opportunities for Structure Therapeutics and Nuvectis Pharma
0.52 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Structure and Nuvectis is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Structure Therapeutics America and Nuvectis Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuvectis Pharma and Structure Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Structure Therapeutics American are associated (or correlated) with Nuvectis Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuvectis Pharma has no effect on the direction of Structure Therapeutics i.e., Structure Therapeutics and Nuvectis Pharma go up and down completely randomly.
Pair Corralation between Structure Therapeutics and Nuvectis Pharma
Given the investment horizon of 90 days Structure Therapeutics American is expected to generate 1.08 times more return on investment than Nuvectis Pharma. However, Structure Therapeutics is 1.08 times more volatile than Nuvectis Pharma. It trades about 0.04 of its potential returns per unit of risk. Nuvectis Pharma is currently generating about 0.01 per unit of risk. If you would invest 2,370 in Structure Therapeutics American on November 2, 2024 and sell it today you would earn a total of 685.00 from holding Structure Therapeutics American or generate 28.9% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Structure Therapeutics America vs. Nuvectis Pharma
Performance |
| Timeline |
| Structure Therapeutics |
| Nuvectis Pharma |
Structure Therapeutics and Nuvectis Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Structure Therapeutics and Nuvectis Pharma
The main advantage of trading using opposite Structure Therapeutics and Nuvectis Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Structure Therapeutics position performs unexpectedly, Nuvectis Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuvectis Pharma will offset losses from the drop in Nuvectis Pharma's long position.| Structure Therapeutics vs. Day One Biopharmaceuticals | Structure Therapeutics vs. X4 Pharmaceuticals | Structure Therapeutics vs. Inozyme Pharma | Structure Therapeutics vs. Acumen Pharmaceuticals |
| Nuvectis Pharma vs. Replimune Group | Nuvectis Pharma vs. Lyra Therapeutics | Nuvectis Pharma vs. Kronos Bio | Nuvectis Pharma vs. Gossamer Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Complementary Tools
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |